Clinical Trial Update: Zilver PTX Drug-Eluting Peripheral Stent Study [NA]

View source ↗

Summary

This clinical trial (NCT01348425) evaluating the Zilver PTX paclitaxel-eluting peripheral stent for Peripheral Arterial Disease has completed and posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Zilver PTX Drug-Eluting Peripheral Stent (paclitaxel-eluting peripheral stent)

Snippet

Sponsor: Cook Group Incorporated | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED | Results posted: 2014-04-16